98 related articles for article (PubMed ID: 2511259)
1. [Galactosyltransferase isozyme II (GT-II) as a new tumor marker for ovarian cancers--especially for clear cell carcinoma].
Nozawa S; Kiguchi K; Yajima M; Udagawa Y; Sakuma T; Iizuka R; Narisawa S; Sakayori M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1341-7. PubMed ID: 2511259
[TBL] [Abstract][Full Text] [Related]
2. [The usefulness and limitation of sugar antigen in ovarian cancers--with special reference to a new tumor marker, CA54/61].
Nozawa S
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1147-51. PubMed ID: 2499263
[TBL] [Abstract][Full Text] [Related]
3. Characterization and immunoassay of human tumor-associated galactosyltransferase isoenzyme II.
Uemura M; Winant RC; Sikic BI; Brandt AE
Cancer Res; 1988 Sep; 48(18):5325-34. PubMed ID: 3136919
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated galactosyltransferase as a new tumor marker for ovarian clear cell carcinoma.
Nozawa S; Yajima M; Sakuma T; Udagawa Y; Kiguchi K; Sakayori M; Narisawa S; Iizuka R; Uemura M
Cancer Res; 1990 Feb; 50(3):754-9. PubMed ID: 2105162
[TBL] [Abstract][Full Text] [Related]
5. [On the clinical usefulness of a few sugar antigens and a galactosyl-transferase].
Nozawa S; Izumi S; Sakayori M; Narisawa S; Kojima K; Iizuka R; Iwamori M; Nagai Y
Hum Cell; 1988 Mar; 1(1):37-45. PubMed ID: 3155288
[TBL] [Abstract][Full Text] [Related]
6. Immunoassay of serum galactosyltransferase isoenzyme II in cancer patients and control subjects.
Uemura M; Winant RC; Brandt AE
Cancer Res; 1988 Sep; 48(18):5335-41. PubMed ID: 3136920
[TBL] [Abstract][Full Text] [Related]
7. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].
Nozawa S; Udagawa Y; Ito K; Susumu N; Sasaki H; Aoki D
Gan To Kagaku Ryoho; 1993 Feb; 20(2):279-85. PubMed ID: 8434967
[TBL] [Abstract][Full Text] [Related]
8. Mouse monoclonal antibodies which recognize a human (beta 1-4)galactosyl-transferase associated with tumor in body fluids.
Uemura M; Sakaguchi T; Uejima T; Nozawa S; Narimatsu H
Cancer Res; 1992 Nov; 52(22):6153-7. PubMed ID: 1423258
[TBL] [Abstract][Full Text] [Related]
9. Galactosyltransferase associated with tumor in patients with ovarian cancer: factors involved in elevation of serum galactosyltransferase.
Saitoh E; Aoki D; Susumu N; Udagawa Y; Nozawa S
Int J Oncol; 2003 Aug; 23(2):303-10. PubMed ID: 12851678
[TBL] [Abstract][Full Text] [Related]
10. Uridine 5'-diphosphate-galactose:glycoprotein galactosyltransferase activity in the ovarian cancer patient.
Bhattacharya M; Chatterjee SK; Barlow JJ
Cancer Res; 1976 Jun; 36(6):2096-101. PubMed ID: 57828
[TBL] [Abstract][Full Text] [Related]
11. [Applications of tumor markers to the screening of endometrial and ovarian cancers].
Nozawa S; Takamatsu K; Tsukazaki K; Udagawa Y
Nihon Rinsho; 1996 Jun; 54(6):1665-73. PubMed ID: 8691627
[TBL] [Abstract][Full Text] [Related]
12. [Application of monoclonal antibody OC 125 in gynecological oncology].
Wu AR; Wang EY; Wang XX; Jia XH; Li L
Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis].
Nozawa S; Udagawa Y; Ito K; Nishimura H; Yakushiji M; Shiota M; Noda K; Yajima M; Ohkura H; Murae M
Gan To Kagaku Ryoho; 1994 Mar; 21(4):507-16. PubMed ID: 8129392
[TBL] [Abstract][Full Text] [Related]
14. Elevation of 4 beta-galactosyltransferase activity for paragloboside synthesis in sera of patients with cancer.
Nishiwaki S; Taki T; Handa N; Hattori N; Takeshita K; Endo M; Handa S
Cancer Res; 1992 Apr; 52(7):1875-80. PubMed ID: 1551117
[TBL] [Abstract][Full Text] [Related]
15. Murine monoclonal antibodies against galactosyltransferase from the ascites of ovarian cancer patients.
Chatterjee SK; Bhattacharya M; Barlow JJ
Cancer Res; 1984 Dec; 44(12 Pt 1):5725-32. PubMed ID: 6209001
[TBL] [Abstract][Full Text] [Related]
16. [Preparative isolation of human galactosyltransferase. A comparison of methods].
Mikhaĭlov AD; Zhordaniia KI
Biokhimiia; 1990 Nov; 55(11):2103-7. PubMed ID: 2128192
[TBL] [Abstract][Full Text] [Related]
17. [Clinical usefulness of tumor markers for the diagnosis of ovarian cancer].
Ito K; Udagawa Y; Nozawa S
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1964-70. PubMed ID: 1417005
[TBL] [Abstract][Full Text] [Related]
18. Tissue polypeptide antigen, galactosyltransferase isoenzyme II and pancreatic oncofetal antigen serum determination: role in pancreatic cancer diagnosis.
Basso D; Fabris C; Panucci A; Del Favero G; Angonese C; Plebani M; Petrin P; Burlina A; Naccarato R
Int J Pancreatol; 1988; 3 Suppl 1():S95-100. PubMed ID: 3145303
[TBL] [Abstract][Full Text] [Related]
19. Critical comments on galactosyltransferase.
Pohl AL
Cancer Detect Prev; 1984; 7(4):299-310. PubMed ID: 6435872
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
